CDNA CareDx Inc

Price (delayed)

$25.91

Market cap

$1.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.95

Enterprise value

$1.22B

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
The revenue has increased by 39% YoY and by 4.1% QoQ
CDNA's gross profit is up by 38% year-on-year and by 3.4% since the previous quarter
The company's quick ratio fell by 37% YoY but it rose by 9% QoQ
CareDx's net income has plunged by 62% from the previous quarter
CareDx's EPS has plunged by 61% from the previous quarter

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
53.22M
Market cap
$1.38B
Enterprise value
$1.22B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3
Price to sales (P/S)
4.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.97
Earnings
Revenue
$308.41M
EBIT
-$51.02M
EBITDA
-$38.23M
Free cash flow
-$27.9M
Per share
EPS
-$0.95
Free cash flow per share
-$0.53
Book value per share
$8.63
Revenue per share
$5.82
TBVPS
$8.71
Balance sheet
Total assets
$546.71M
Total liabilities
$89.17M
Debt
$16.73M
Equity
$457.54M
Working capital
$344.57M
Liquidity
Debt to equity
0.04
Current ratio
6.15
Quick ratio
5.75
Net debt/EBITDA
4.06
Margins
EBITDA margin
-12.4%
Gross margin
66.7%
Net margin
-16.1%
Operating margin
-15.5%
Efficiency
Return on assets
-8.9%
Return on equity
-10.6%
Return on invested capital
-40.6%
Return on capital employed
-10.6%
Return on sales
-16.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
3.6%
1 week
20.62%
1 month
-1.26%
1 year
-70.59%
YTD
-43.03%
QTD
20.62%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$308.41M
Gross profit
$205.72M
Operating income
-$47.92M
Net income
-$49.62M
Gross margin
66.7%
Net margin
-16.1%
The operating income has dropped by 172% year-on-year and by 61% since the previous quarter
The net margin has dropped by 164% year-on-year and by 56% since the previous quarter
CareDx's operating margin has plunged by 94% YoY and by 55% from the previous quarter
CareDx's net income has plunged by 62% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
3
P/S
4.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.97
CareDx's EPS has plunged by 61% from the previous quarter
The stock's price to book (P/B) is 72% less than its 5-year quarterly average of 10.2 and 56% less than its last 4 quarters average of 6.6
The equity has decreased by 3% YoY
The price to sales (P/S) is 62% less than the last 4 quarters average of 11.3 and 59% less than the 5-year quarterly average of 10.4
The revenue has increased by 39% YoY and by 4.1% QoQ

Efficiency

How efficient is CareDx business performance
CDNA's return on assets has dropped by 162% year-on-year and by 62% since the previous quarter
The ROE has plunged by 152% YoY and by 63% from the previous quarter
CareDx's ROS has plunged by 146% YoY and by 51% from the previous quarter
The ROIC has shrunk by 102% YoY and by 25% QoQ

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's quick ratio fell by 37% YoY but it rose by 9% QoQ
CDNA's current ratio is down by 36% year-on-year but it is up by 10% since the previous quarter
The debt is 96% smaller than the equity
The debt has declined by 9% year-on-year and by 3.8% since the previous quarter
The equity has decreased by 3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.